SCHEDULE: Hayfin Entities Reduce HeartFlow Stake
Ownership Filing Amendment
Several Hayfin entities have reported a reduction in their beneficial ownership of HeartFlow, Inc. Class A Common Stock, with aggregate holdings now below 5% for some.
Summary
- This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of HeartFlow, Inc. Class A Common Stock by various Hayfin entities.
- The reporting persons, including Hayfin Management Holdings Limited, Hayfin Heartflow UK Limited, and several other Hayfin-affiliated entities, have collectively reduced their holdings.
- Specifically, the filing details the disposition of significant numbers of shares during the three months ended March 31, 2026.
- As a result of these dispositions, the aggregate beneficial ownership for some reporting persons has fallen below the 5% threshold.
- The total outstanding shares of Class A Common Stock as of February 28, 2026, were reported as 85,757,754.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the reported dispositions of shares by multiple entities, indicating a reduction in investment rather than an increase or sustained holding.
Negatives
- Several Hayfin entities have significantly reduced their holdings in HeartFlow, Inc. Class A Common Stock.
- The aggregate beneficial ownership for multiple reporting persons has fallen below 5%.
Future Outlook
The filing primarily reports past transactions (dispositions) and current ownership levels, rather than providing forward-looking statements or guidance for HeartFlow, Inc.
Industry Context
StockSavvy.ai notes that Schedule 13G filings typically report passive ownership stakes by institutional investors. A reduction in holdings by significant entities like those affiliated with Hayfin can sometimes signal a shift in investment strategy or a rebalancing of portfolios, which may be of interest to market observers tracking institutional activity in the medical technology sector.
Stakeholder Impact
- Shareholders may note the reduction in holdings by significant entities, which could influence market perception of institutional confidence in HeartFlow, Inc.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | Fiscal year ended |
| 2026-02-28 | Date as of which shares of Class A Common Stock outstanding were reported |
| 2026-03-18 | Date Heartflow, Inc.'s Annual Report on Form 10-K was filed |
| 2026-03-31 | End of the three-month period during which share dispositions occurred |
| 2026-05-11 | Date of certification and signature for the filing |
Keywords
HeartFlow, Schedule 13G, SEC Filing, Beneficial Ownership, Hayfin, Stock Disposition, Class A Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.